Skip to main content

Month: February 2023

BridgeBio Pharma to Host Educational Roundtable with Esteemed Achondroplasia Expert on February 16, 2023

PALO ALTO, Calif., Feb. 13, 2023 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced that members of its management team will host a roundtable discussion on Thursday, February 16 at 12:00 pm ET with Melita Irving, clinical geneticist at Guy’s and St Thomas’ NHS Foundation Trust, London, UK and investigator for the infigratinib clinical program at the Evelina London Children’s Hospital. Dr. Irving, a key opinion leader who specializes in genetic and rare conditions and specifically in skeletal dysplasia, will provide an overview of the medical complications as well as the social and emotional impact experienced by those living with achondroplasia. Dr. Irving has established...

Continue reading

Savaria Announces Preliminary Fiscal 2022 Results and 2023 Forecast

LAVAL, Québec, Feb. 13, 2023 (GLOBE NEWSWIRE) — Savaria Corporation (“Savaria”) (TSX: SIS), a global leader in the accessibility industry, is pleased to provide preliminary results for its 2022 year-end and financial guidance for its fiscal 2023. Preliminary 2022 ResultsRevenue should be approximately $789 million compared to $661 million in 2021, an increase of approximately 19%. Adjusted EBITDA should be approximately $120 million compared to $100 million in 2021, an increase of approximately 20% (1). Operating income should be approximately $64 million compared to $36 million in 2021.(1) Please refer to the sections below entitled “Compliance with International Financial Reporting Standards (“IFRS”)”. These preliminary results are based on information available to Savaria as of the date of this release and are subject to...

Continue reading

Papa Johns is Flipping Pizza Night on its Head with New Crispy Parm Pizza

The new flippin’ awesome innovation adds cheese where we’ve never had it before – the bottom of the pizza!NEW Papa Johns Crispy Parm Pizza Crispy Parm Pizza is the latest menu innovation from Papa Johns, following Papa Bowls and Papa Bites.ATLANTA, Feb. 13, 2023 (GLOBE NEWSWIRE) — Papa Johns continues to showcase its position as a leader in product innovation, this time by unveiling a pizza that takes cheese where we’ve never had it before – underneath the crust. Behold the Golden Crispy Goodness of the all-new Papa Johns Crispy Parm Pizza! Because there’s no such thing as too much cheese, we’ve added delicious parmesan cheese on the bottom, too. Go ahead, flip it over and look for yourself! Papa Johns Crispy Parm Pizza features our thin crust seasoned with a blend of shredded parmesan-Romano cheeses and can be ordered with...

Continue reading

Churchill Reports Balance of 2022 Results and 2023 Drilling Plans for the Taylor Brook and Florence Lake Nickel Projects

Fig. 1 Fig. 1Fig. 2 Fig. 2Fig. 3 Fig. 3TORONTO, Feb. 13, 2023 (GLOBE NEWSWIRE) — Churchill Resources Inc. (“Churchill” or the “Company”) (TSXV: CRI) is pleased to announce final 2022 results from its work on the Florence Lake and Taylor Brook properties both in Newfoundland and Labrador (NL), Canada. Paul Sobie, CEO, remarked that “2022 was our first full year working our NL projects and we accomplished much in advancing the high-grade nickel discovery potential on both Taylor Brook and Florence Lake. Drilling and channel sampling of the partially outcropping Layden Intrusive on Taylor Brook has successfully exposed both high-grade massive and net textured nickel-copper-cobalt mineralization at shallow depths over approximately 200m of strike – now we must follow those intersections to depth. In all, CRI has intersected...

Continue reading

Sotera Health Confirms Preliminary 2022 Full-Year Guidance in Conjunction with Incremental Debt Financing

CLEVELAND, Feb. 13, 2023 (GLOBE NEWSWIRE) — Sotera Health Company (“Sotera Health” or the “Company”) (NASDAQ: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced its intention to enter into a new senior secured Term Loan B facility in an aggregate principal amount of $425 million, which is expected to fund and close during the first quarter. The Company plans to use proceeds of this debt financing, along with cash on hand, to: a) fund a previously announced planned $408 million ethylene oxide litigation settlement in Cook County, IL, b) pay down existing borrowings under the Company’s revolving credit facility, and c) further enhance liquidity. Preliminary Financial Results for the Year Ended December 31, 2022 Our...

Continue reading

Monarch Reports Its Second Quarter Results and Final Closing of the Private Placement

Not for distribution to U.S. news wire services or dissemination in the United States MONTRÉAL, Feb. 13, 2023 (GLOBE NEWSWIRE) — MONARCH MINING CORPORATION (“Monarch” or the “Corporation”) (TSX: GBAR) (OTCQB: GBARF) reported its results today for the second quarter ended December 31, 2022. Amounts are in Canadian dollars unless otherwise indicated. Summary of financial results(In dollars except per-share data) Three months endedDecember 31, 2022 Six months endedDecember 31, 2022  2022   2021   2022   2021  Revenues 544,390   –   2,549,995   –  Cost of sales (874,258 ) –   (17,546,397 ) –  Loss from mine operations (329,868 ) –   (14,996,402 ) –  Administration expenses (1,299,168 ) (2,374,268 ) (2,227,953 ) (4,289,297 )Care and maintenance expenses (873,851 ) –   (873,851 ) –  Exploration expenses (66,555 ) (714,471 ) (207,868 ) (2,444,166 )Operating...

Continue reading

B2Gold Corp. Announces Acquisition of Sabina Gold & Silver Corp.

Black River Gold Project Black River Gold ProjectVANCOUVER, British Columbia, Feb. 13, 2023 (GLOBE NEWSWIRE) — B2Gold Corp. (TSX: BTO, NYSE MKT: BTG, NSX: B2G) (“B2Gold”) and Sabina Gold & Silver Corp (“Sabina”) are pleased to announce that the parties have entered into a definitive agreement (the “Agreement”) pursuant to which B2Gold has agreed to acquire all of the issued and outstanding shares of Sabina (the “Transaction”). The Transaction will result in B2Gold acquiring Sabina’s 100% owned Back River Gold District located in Nunavut, Canada. The Back River Gold District consists of five mineral claims blocks along an 80 kilometre (“km”) belt. The most advanced project in the district, Goose, is fully permitted, construction ready, and has been de-risked with significant infrastructure currently in place. B2Gold has...

Continue reading

Movella Announces Trading of Common Stock on Nasdaq Global Market

Movella Announces Trading on the Nasdaq Global Stock Market on Feb. 13, 2023 Movella Announces Trading on the Nasdaq Global Stock Market on Feb. 13, 2023HENDERSON, Nev., Feb. 13, 2023 (GLOBE NEWSWIRE) — Movella Holdings Inc. (NASDAQ:MVLA) (“Movella”), a global leader in the digitization of movement, will begin trading its common stock and warrants on the Nasdaq Global Market under the ticker symbols “MVLA” and “MVLAW”, respectively, today, following its successful merger with Pathfinder Acquisition Corp. (“Pathfinder”), a special purpose acquisition corporation, on Feb. 10, 2023. Movella’s advanced inertial sensor technology, together with its software and analytics, represent a highly differentiated full-stack solution for the digitization of movement for customers in entertainment, health & sports, and automation...

Continue reading

Aprea Therapeutics Announces One-for-Twenty Reverse Stock Split

DOYLESTOWN, Pa., Feb. 13, 2023 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE) (the “Company”), a biopharmaceutical company focused on developing novel synthetic lethality-based cancer therapeutics targeting DNA damage response (DDR) pathways, today announced a one-for-twenty reverse stock split of the Company’s common stock, par value $0.001, which became effective at 5:00 pm Eastern Time on February 10, 2023. The Company’s common stock will trade on the Nasdaq Global Select Market on a split-adjusted basis beginning on February 13, 2023, under the Company’s existing trading symbol “APRE”. The Company is implementing the reverse stock split as planned to increase the per share price of its common stock to regain compliance with the listing requirements of the Nasdaq Global Select Market. The reverse stock split will...

Continue reading

Axogen, Inc. Appoints Jens Schroeder Kemp as Chief Marketing Officer

ALACHUA, Fla. and TAMPA, Fla., Feb. 13, 2023 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the appointment of Jens Schroeder Kemp to the newly created role of Chief Marketing Officer. Kemp brings more than 20 years of strategic marketing, sales, and business development experience in high-growing medical technology. As a member of the Axogen executive leadership team, Kemp will report directly to Karen Zaderej, Chairman, CEO and President, and will oversee the development and execution of the company’s marketing strategies. “I am thrilled to welcome Jens to Axogen. His extensive strategic marketing experience and track record of growth is an ideal addition to our team,” commented Ms. Zaderej. “We look forward...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.